Variants of Guillain-Barré syndrome: Low incidence but high impact

Journal of Neurology

Volumn 256, Issue 11, 2009, Pages 1909-1910

  Lehmann, Helmar C ^a   Hartung, Hans Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; NOTE;

DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE;

EID: 73449143906     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5253-9     Document Type: Note

References (20)

1. Fisher CM (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, areflexia). New Engl J Med 255:57-65
2. Frenzen P (2008) Economic cost of Guillain-Barré syndrome in the United States. Neurology 71:21-27
3. Godschalk PC, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, Brochu D, Li J, Yuki N, Jacobs BC, van Belkum A, Endtz HP (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. J Clin Invest 114:1659-1665 (Pubitemid 40385557)
4. Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ (1999) Monoclonal antibodies raised against Guillain-Barré syndrome-Associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 104:697-708 (Pubitemid 29536355)
5. Guillain G, Barré JA, Strohl A (1916) Sur un syndrome de radiculone v́rite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bull Soc Méd Hôp Paris 40
6. Henderson R, Lawn N, Fletcher D, McClelland R, Wijdicks E (2003) The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology 60:17-21 (Pubitemid 36070637)
7. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605
8. Hughes RA, Cornblath DR (2005) Guillain-Barré syndrome. Lancet 366:1653-1666
9. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immunemediated disorders of the peripheral nervous system. Muscle Nerve 30:131-156 (Pubitemid 38982218)
10. Lehmann HC, Kohne A, zu Horste GM, Kieseier BC (2007) Incidence of Guillain-Barré syndrome in Germany. J Peripher Nerv Syst 12:285
11. Lyu R, Chen S (2004) Acute multiple cranial neuropathy: A variant of Guillain-Barré syndrome? Muscle Nerve 30:433-436 (Pubitemid 39288145)
12. McGrogan A, Madle G, Seaman H, de Vries C (2009) The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 32:150-163
13. Ropper A (1994) Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 51:671-675 (Pubitemid 24201885)
14. Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol (this issue
15. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27:3956-3967 (Pubitemid 46597169)
16. Ter Bruggen J, van der Meché F, de Jager A, Polman C (1998) Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome. Muscle Nerve 21:239-242 (Pubitemid 28079745)
17. van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7:939-950
18. Willison HJ, Yuki N (2002) Peripheral neuropathies and antiglycolipid antibodies. Brain 125:2591-2625
19. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 101:11404-11409 (Pubitemid 39038359)
20. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K (2001) Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49:712-720 (Pubitemid 32530237)